CD80 and myeloid sarcoma: In summary, in the context of MS/EAE, DCs rely on the CD80/CD86-CD28 axis to induce Treg cell generation, and Tregs rely on the CTLA-4-CD80/86 axis to inhibit DC immunogenicity, and induce the generation of tolDCs, thereby forming a protective signaling loop.